Mecuris provides an online platform that functions as a digital workshop where patient-specific prostheses and orthoses can be tailored and realized using 3D printing. The platform’s digital process chain enables CPOs and users to co-create aids optimized in terms of color, form and function. The company plans to expand its platform into the field of orthotics at the end of March. It will use the recent funding to increase penetration of the European market. Mecuris is based in Munich, Germany. The company raised €3.6m in growth funding to support these initiatives. Mecuris provides an intuitive web-based platform that enables individual and custom-made production of orthopaedic aids, with subsequent manufacturing using 3D printing. Its offerings include orthoses (e.g., cervical spine stabilizers), prostheses (e.g., artificial limbs), and equipment such as covers for below-knee prostheses. The company collaborates with orthopaedic suppliers, medical supply stores, and orthopaedic clinics, offering a full-service package through delivery of the manufactured products. Design data are adjusted to a patient’s anatomy in an automated fashion based on digital patient data (CT, scanning, photos). Founded in 2016 as a spin-off of the Hospital of the Ludwig-Maximilians-University (LMU) Munich, Mecuris is headquartered in Munich, Germany. It raised a seed funding round of undisclosed amount from High‑Tech Gründerfonds (HTGF) and Bayern Kapital and intends to use the funds to expand the platform and develop additional applications.

Total raised

$4M

Funding rounds

2

Latest round

Equity

Latest activity

Jan 2020